Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 436

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution

Anghileri, Matteo, Miceli, Rosalba, Fiore, Marco, Mariani, Luigi, Ferrari, Andrea, Mussi, Chiara, Lozza, Laura, Collini, Paola, Olmi, Patrizia, Casali, Paolo G., Pilotti, Silvana, Gronchi, Alessandro·2006·Cancer

Abstract

BACKGROUND.: The authors explored the prognostic factors and clinical outcomes of patients who had malignant peripheral nerve sheath tumors (MPNST) with and without neurofibromatosis type 1 (NF‐1). METHODS.: Two hundred five patients with localized MPNST who underwent surgery at the Istituto Nazionale per lo Studio e la Cura dei Tumori (Milan, Italy) over 25 years were reviewed. Forty‐six patients had concomitant NF‐1 syndrome, and 159 patients did not. Local recurrence, distant metastases, and survival rates were studied. RESULTS.: One hundred thirty patients presented with primary disease, and 75 patients had locally recurrent tumors. The disease‐specific mortality rate was 43% at 10 years, with a continuously disease‐free survival rate of no greater than 40%. Presentation with either primary or recurrent disease, tumor size, and tumor site (trunk vs. extremity) were the strongest independent predictors of survival. Margin status and radiation therapy also played a role, mostly related to their effect on local outcome. Pathologic grade influenced distant metastases, but only a trend for survival could be observed. No significant independent differences between patients with and without NF‐1 were observed. CONCLUSIONS.: To the authors' knowledge, this was among the largest single‐institution series to date. The results confirmed that patients with MPNST share similar prognostic factors with patients who have other soft tissue sarcomas and have some of the worst clinical outcomes. The presence of NF‐1 syndrome per se did not affect survival, but patients with NF‐1 were more likely to have larger tumors. Therefore, such patients should be followed carefully to detect disease as early as possible. Cancer 2006. © 2006 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.22098

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 436

Metadata

Authors
Anghileri, M., Miceli, R., Fiore, M., Mariani, L., Ferrari, A., Mussi, C., Lozza, L., Collini, P., Olmi, P., Casali, P. G., Pilotti, S., & Gronchi, A.
Venue
Cancer
Publisher
Wiley
Published
2006-07-31
Volume
107
Issue
5
Pages
1065-1074
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2032220244
Cited by
436
References
24
FWCI
8.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution. https://app.cochat.ai/papers/10.1002/cncr.22098
The paper
Anghileri, M., Miceli, R., Fiore, M., Mariani, L., Ferrari, A., Mussi, C., Lozza, L., Collini, P., Olmi, P., Casali, P. G., Pilotti, S., & Gronchi, A. (2006). Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution. Cancer. https://doi.org/10.1002/cncr.22098

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.